SEMAGLUTIDE / WHAT IT IS
What Is Semaglutide, and How Does GLP-1 Help?
You’ll see which natural hormone it copies, why it lasts, and what it can’t promise you.
What’s the short, honest answer?
Novo Nordisk built semaglutide from an older medicine so each dose would last longer and copy GLP-1, a hormone the intestine gives off during meals. That hormone signals insulin, slows the stomach, and quiets hunger, while semaglutide’s longer stay allows a shot once a week or a pill each day. Its uses cover type 2 diabetes, weight, some risks for the heart, and MASH, a fatty liver illness. I’d keep the trade-off in view for you: those uses have study support, but nausea and other harms aren’t imaginary.
How does the GLP-1 gut hormone help blood sugar and hunger?
Doctors call this mealtime hormone GLP-1. Semaglutide copies GLP-1 and sends the same messages to cells in your pancreas, stomach, liver, and brain. When blood sugar rises, GLP-1 tells the pancreas to release insulin. It also slows stomach emptying and tells the liver to add less sugar to your blood.
The GLP-1 message in the brain can ease hunger too. Slower stomach emptying isn’t the whole answer. The how does semaglutide work page explains both parts. Novo Nordisk developed semaglutide from liraglutide, an older drug that works in the same way [6].
How does the 31-amino-acid semaglutide peptide last so long?
A semaglutide peptide is a chain of 31 amino acids, the small parts that make proteins. About 94% of the chain matches GLP-1, a hormone from your intestine. The close match allows the drug to do much of the hormone’s work. That’s how a few changes make each dose last much longer.
Lab papers call the changed spots 8, 34, and 26, but those numbers won’t help you choose care. One change slows DPP-4, the enzyme that clears your natural GLP-1. Another lets the blood protein albumin carry semaglutide [7]. A 2024 review found the effect can last between weekly shots [8]. It still can’t tell whether semaglutide fits you.
What has Semaglutide been approved to treat?
Semaglutide’s approved as an injection given weekly and a daily tablet. It treats type 2 diabetes; doctors also use it for lasting weight care. Adults carrying excess weight who also have heart disease may take it to lower heart risk. In 2025, MASH joined the list; that’s a fatty liver illness that causes swelling and scars [6], but your prescriber must decide whether an approved use fits you.
One weight study, STEP 1, found an average -14.9% change at 68 weeks [2]. A heart study found 20% fewer major heart events [4], while kidney work found 24% fewer major kidney events [5]. In a 2025 liver study, 62.9% taking semaglutide lost the swelling, versus 34.3% on placebo, a dummy treatment with no semaglutide [1]. Group results won’t predict your own response.